Live webinar from Singapore: Portfolio analysis - Choosing your communication strategy
Tuesday 1st October 2019 16:00 SGT / 16:00 CST / 17:00 JST
Portfolio Analysis and Optimization concentrates on determining the impact that multiple assets have within therapeutic categories, and how the marketing of these assets impacts on overall strategy. This is an important tool for pharmaceutical companies in today’s market. As they simultaneously develop multiple products that can become extremely costly, portfolio management to improve decision-making can have a significant impact on the bottom line. At its very core, it is about selecting how to allocate resources and marketing efforts across multiple assets.
How we used Conference Live at a series of large and small-scale congresses to measure shifts in customer perceptions over time
Our client planned to have a significant presence at a variety of medical congresses r in both the US and EU. Find out how we effectively measured their performance across a range of KPIs
Our client planned to have a significant presence at a variety of large and small-scale medical congresses in both the US and EU in support of their portfolio of products for a range of degenerative neurological conditions. To understand how their presence had been received, they wanted to collect feedback and explore any shifts in perceptions toward their products and measure their performance across a range of scientific engagement and customer experience KPIs.
Game changer: The role of immersive technologies in the healthcare and pharmaceutical industries
This article, published by Med Ad News August 2019, explores how technological advances in VR/AR are offering new opportunities for conducting healthcare market research.
The next decade promises to be an exciting time for science and innovation. Technological advancements are being made on a daily basis and many of these have the potential to directly impact our everyday lives. In fact, technology is changing at such a rate that it can often seem difficult to keep up. One advancement with the potential to change how we interact with the world is Virtual and Augmented Reality (VR/AR). Since the launch of top-end devices such as the Oculus Rift headset and many simpler, more affordable designs such as the Google Cardboard, interest in VR/AR has sky-rocketed. Coupled with advancements in smartphone technology it is now possible for larger numbers of people to experience VR/AR.
How to conduct an effective epidemiological data review
Clients often ask us if we can triangulate various data sources to fully understand the opportunity for an asset. There are clear benefits - combining primary market research findings with existing data sets provides validity and depth, whilst eliminating many inconsistencies, which helps guide the direction for future marketing strategy and initiatives.
Hasta la vista, maybe? Terminating the Hollywood view of AI in pharma
Marketing Director Julie Denny was recently interviewed by PME Magazine about the use of artificial intelligence in pharma marketing and market research.
Rumours that robots will eventually wipe out humans are the futuristic stuff of Hollywood blockbusters. The real-world story arc is much more uplifting but no less dramatic. When a homeless man in central England was crushed to death by a compaction unit as he slept in the dustbin in 2013, it triggered a response from the UK waste management industry that now sees many refuse trucks fitted with senor technology to detect people in bins. It's an early example of how AI can literally save lives. Fast forward six years and we've now got 'robot doctors' detecting cancers, smart remote monitoring systems managing patients miles from their homes and algorithm-led technologies predicting long-term health based on individuals' DNA. The application of AI in health isn't science fiction, it's happening fast - and it’s positively disrupting patient care.